- UroToday Home
- Pelvic Health & Reconstruction
The Latest Research in Overactive Bladder
Recent Abstracts
-
Assessing Quality-of-Life of Patients Taking Mirabegron for Overactive Bladder.Overactive BladderJanuary 22, 2023
-
Cost-effectiveness of overactive bladder treatments from a US commercial and payer perspective.Overactive BladderJanuary 22, 2023
-
Real-Time Documentation of the Effect of Onabotulinumtoxin A Detrusor Injection in OAB Patients-Preliminary Results.Overactive BladderJanuary 22, 2023
-
Patients' Preferences and Expectations in Overactive Bladder: A Systematic Review.Overactive BladderJanuary 22, 2023
-
Reduced versus standard intradetrusor OnabotulinumtoxinA injections for treatment of overactive bladder.Overactive BladderJanuary 15, 2023
-
The choice of therapeutic agent in female overactive bladder patients in real-world practice.Overactive BladderJanuary 15, 2023
-
Brain Response Induced by Peroneal Electrical Transcutaneous Neuromodulation Invented for Overactive Bladder Treatment, as Detected by Functional Magnetic Resonance Imaging.Overactive BladderJanuary 15, 2023
-
Prospective, Randomized, Multicenter Trial of Peroneal Electrical Transcutaneous NeuroModulation versus Solifenacin in Treatment of Naïve Patients with Overactive Bladder.Overactive BladderJanuary 8, 2023
-
Sacral neuromodulation for overactive bladder using the InterStim and BetterStim systems.Overactive BladderJanuary 8, 2023
-
Development of an implant technique and early experience using a novel implantable pulse generator with a quadripolar electrode array at the tibial nerve for refractory overactive bladder.Overactive BladderJanuary 8, 2023
Beyond the Abstracts
-
Urobiome Changes Differ Based on OAB Treatment in Adult Females - Beyond the AbstractOveractive BladderJanuary 17, 2023
-
A Systematic Review and In Silico Study of Potential Genetic Markers Implicated in Cases of Overactive Bladder - Beyond the AbstractOveractive BladderSeptember 29, 2022
-
Gender Bias in YouTube Videos Describing Common Urology Conditions - Beyond the AbstractOveractive BladderSeptember 1, 2022
-
Combination and Novel Pharmacologic Agents for OAB - Beyond the AbstractOveractive BladderAugust 23, 2022
-
Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWUR - Beyond the AbstractOveractive BladderMay 20, 2022
-
The Influence of Gut Microbiome on Progression of Overactive Bladder Symptoms: A Community-Based 3-Year Longitudinal Study in Aomori, Japan - Beyond the AbstractOveractive BladderFebruary 8, 2022
-
Social Media Analytics of Overactive Bladder Posts: What do Patients Know and Want to Know? - Beyond the AbstractOveractive BladderAugust 9, 2021
-
Outcomes of a Single Trigone-Only vs. 20 Trigone-Sparing Injections of OnabotulinumtoxinA for Refractory Overactive Bladder (OAB) - Beyond the AbstractOveractive BladderJune 1, 2021
-
Racial and Socioeconomic Factors Influence Utilization of Advanced Therapies in Commercially Insured OAB Patients: An Analysis of over 800,000 OAB Patients - Beyond the AbstractOveractive BladderSeptember 14, 2020
-
Is the Addition of Vaginal Electrical Stimulation to Transcutaneous Tibial Nerve Electrical Stimulation More Effective for Overactive Bladder Treatment? a Randomized Controlled Trial - Beyond the AbstractOveractive BladderAugust 21, 2020
